ArticleScientific reports2024

A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database.

Rui Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.